Back to User profile » Prof. Dr. Ingrid Hilger
Papers published by Prof. Dr. Ingrid Hilger:
Methotrexate-coupled nanoparticles and magnetic nanochemothermia for the relapse-free treatment of T24 bladder tumors
Stapf M, Teichgräber U, Hilger I
International Journal of Nanomedicine 2017, 12:2793-2811
Published Date: 6 April 2017
Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki-67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer
Ludwig R, Teran FJ, Teichgraeber U, Hilger I
International Journal of Nanomedicine 2017, 12:1009-1018
Published Date: 7 February 2017
Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia
Stapf M, Pömpner N, Teichgräber U, Hilger I
International Journal of Nanomedicine 2016, 11:485-500
Published Date: 4 February 2016
Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods
Friedrich RP, Janko C, Poettler M, Tripal P, Zaloga J, Cicha I, Dürr S, Nowak J, Odenbach S, Slabu I, Liebl M, Trahms L, Stapf M, Hilger I, Lyer S, Alexiou C
International Journal of Nanomedicine 2015, 10:4185-4201
Published Date: 26 June 2015
Gold nanoparticles allow detection of early-stage edema in mice via computed tomography imaging
Domey J, Teichgräber U, Hilger I
International Journal of Nanomedicine 2015, 10:3803-3814
Published Date: 2 June 2015
Magnetic thermoablation stimuli alter BCL2 and FGF-R1 but not HSP70 expression profiles in BT474 breast tumors
Stapf M, Pömpner N, Kettering M, Hilger I
International Journal of Nanomedicine 2015, 10:1931-1939
Published Date: 10 March 2015
The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels
Franke K, Kettering M, Lange K, Kaiser WA, Hilger I
International Journal of Nanomedicine 2013, 8:351-363
Published Date: 20 January 2013